Cargando…
The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19
INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlact...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265175/ https://www.ncbi.nlm.nih.gov/pubmed/37144596 http://dx.doi.org/10.1111/crj.13628 |
_version_ | 1785058478289584128 |
---|---|
author | Alshammary, Amal F. AlQarni, Hassan M. Farzan, Raed Ali Khan, Imran Vennu, Vishal |
author_facet | Alshammary, Amal F. AlQarni, Hassan M. Farzan, Raed Ali Khan, Imran Vennu, Vishal |
author_sort | Alshammary, Amal F. |
collection | PubMed |
description | INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlactatemia with mortality among critically ill Covid‐19 patients admitted to the intensive care unit (ICU). METHODS: In this single‐centre retrospective study, we included 171 patients aged ≥18 years with confirmed Covid‐19 admitted to the ICU at a tertiary healthcare clinic in the Eastern region of Saudi Arabia between 1 March 2020 and 31 January 2021. Patients were divided into two groups: survivor and non‐survivor. The survivors have been identified as the patients discharged from the ICU alive. The VTE risk was defined using a Padua prediction score (PPS) >4. The blood lactate concentration (BLC) cut‐off value >2 mmol/L was used to determine the blood hyperlactatemia. RESULTS: Multi‐factor Cox analysis showed that PPS >4 and BLC >2 mmol/L were more likely to be significantly associated with higher odds of ICU mortality in critically ill Covid‐19 patients (hazard ratio [HR] = 2.80, 95% confidence interval [CI] = 1.00–8.08, p = 0.050; HR = 3.87, 95% CI = 1.12–13.45, p = 0.033, respectively). The Area under the Curve for VTE and blood hyperlactatemia were 0.62 and 0.85, respectively. CONCLUSION: VTE risk and blood hyperlactatemia have been associated with a higher mortality risk in critically ill Covid‐19 patients who are hospitalized in the ICU in Saudi Arabia. According to our findings, these people needed more effective VTE prevention strategies based on a personalized assessment of their risk of bleeding. Moreover, persons without diabetes and other groups with a high risk of dying from COVID‐19 may be recognized by measuring glucose as having elevated glucose and lactate jointly. |
format | Online Article Text |
id | pubmed-10265175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102651752023-06-15 The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 Alshammary, Amal F. AlQarni, Hassan M. Farzan, Raed Ali Khan, Imran Vennu, Vishal Clin Respir J Original Articles INTRODUCTION: Coronavirus disease 2019 (Covid‐19) following venous thromboembolism (VTE) and blood hyperlactatemia are associated with higher mortality. However, reliable biomarkers for this association remain to be elucidated. This study investigated the associations of VTE risk and blood hyperlactatemia with mortality among critically ill Covid‐19 patients admitted to the intensive care unit (ICU). METHODS: In this single‐centre retrospective study, we included 171 patients aged ≥18 years with confirmed Covid‐19 admitted to the ICU at a tertiary healthcare clinic in the Eastern region of Saudi Arabia between 1 March 2020 and 31 January 2021. Patients were divided into two groups: survivor and non‐survivor. The survivors have been identified as the patients discharged from the ICU alive. The VTE risk was defined using a Padua prediction score (PPS) >4. The blood lactate concentration (BLC) cut‐off value >2 mmol/L was used to determine the blood hyperlactatemia. RESULTS: Multi‐factor Cox analysis showed that PPS >4 and BLC >2 mmol/L were more likely to be significantly associated with higher odds of ICU mortality in critically ill Covid‐19 patients (hazard ratio [HR] = 2.80, 95% confidence interval [CI] = 1.00–8.08, p = 0.050; HR = 3.87, 95% CI = 1.12–13.45, p = 0.033, respectively). The Area under the Curve for VTE and blood hyperlactatemia were 0.62 and 0.85, respectively. CONCLUSION: VTE risk and blood hyperlactatemia have been associated with a higher mortality risk in critically ill Covid‐19 patients who are hospitalized in the ICU in Saudi Arabia. According to our findings, these people needed more effective VTE prevention strategies based on a personalized assessment of their risk of bleeding. Moreover, persons without diabetes and other groups with a high risk of dying from COVID‐19 may be recognized by measuring glucose as having elevated glucose and lactate jointly. John Wiley and Sons Inc. 2023-05-05 /pmc/articles/PMC10265175/ /pubmed/37144596 http://dx.doi.org/10.1111/crj.13628 Text en © 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Alshammary, Amal F. AlQarni, Hassan M. Farzan, Raed Ali Khan, Imran Vennu, Vishal The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title | The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title_full | The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title_fullStr | The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title_full_unstemmed | The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title_short | The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid‐19 |
title_sort | risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with covid‐19 |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265175/ https://www.ncbi.nlm.nih.gov/pubmed/37144596 http://dx.doi.org/10.1111/crj.13628 |
work_keys_str_mv | AT alshammaryamalf theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT alqarnihassanm theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT farzanraed theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT alikhanimran theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT vennuvishal theriskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT alshammaryamalf riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT alqarnihassanm riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT farzanraed riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT alikhanimran riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 AT vennuvishal riskofvenousthromboembolismandbloodhyperlactatemiaisassociatedwithincreasedmortalityamongcriticallyillpatientswithcovid19 |